KR100748390B1 - 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 - Google Patents
상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 Download PDFInfo
- Publication number
- KR100748390B1 KR100748390B1 KR1020050108344A KR20050108344A KR100748390B1 KR 100748390 B1 KR100748390 B1 KR 100748390B1 KR 1020050108344 A KR1020050108344 A KR 1020050108344A KR 20050108344 A KR20050108344 A KR 20050108344A KR 100748390 B1 KR100748390 B1 KR 100748390B1
- Authority
- KR
- South Korea
- Prior art keywords
- growth factor
- film formulation
- film
- hydroxypropylmethylcellulose
- chitosan
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0095—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Composite Materials (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
처방 | 조성 (100g 중) |
DWF1 | 상피세포성장인자 1mg 키토산 1g 글리세린 10g 물 적량 |
DWF2 | 상피세포성장인자 1mg 키토산 1g 하이드록시프로필메틸셀룰로오즈 50cps 10g 글리세린 10g 물 적량 |
DWF3 | 상피세포성장인자 1mg 키토산 1g 하이드록시프로필메틸셀룰로오즈 50cps 5g 하이드록시프로필메틸셀룰로오즈 4000cps 1g 글리세린 10g 물 적량 |
DWF4 | 상피세포성장인자 1mg 키토산 1g 젤라틴 10g 글리세린 10g 물 적량 |
DWF5 | 상피세포성장인자 1mg 키토산 1g 폴리에틸렌글리콜 10g 글리세린 10g 물 적량 |
DWF6 | 상피세포성장인자 1mg 키토산 1g 폴리비닐피롤리돈 10g 글리세린 10g 물 적량 |
구분 | 성상 | 두께 | 수분함량(%) | 상피세포성장인자 순도(%) |
DWF1 (키토산 단독) | 오그라듬 | 50 ± 10 μm | 20 ± 5 % | 92 ± 0.5 % |
DWF2 (하이드록시프로필메틸셀룰로오즈50cps) | 약간 오그라듬 | 100 ± 10 μm | 20 ± 2 % | 94 ± 0.5 % |
DWF3 (하이드록시프로필메틸셀룰로오즈50cps/ 하이드록시프로필메틸셀룰로오즈4000cps) | 성상 우수 | 150 ± 10 μm | 20 ± 3 % | 95 ± 0.6 % |
DWF4 (젤라틴) | 성상 우수 | 140 ± 10 μm | 20 ± 4 % | 87 ± 0.9 % |
DWF5 (폴리에틸렌글리콜) | 성상 우수 | 100 ± 10 μm | 20 ± 5 % | 93 ± 0.5 % |
DWF6 (폴리비닐피롤리돈) | 성상 우수 | 100 ± 10 μm | 20 ± 3 % | 93 ± 0.6 % |
처방 | 조성 | 함량(100g중) | 점도 | 두께 |
DWF7 | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | 10.0 mg 5.0 g 10.0 g 1.0 g 0.05 g 10.0g 적량 | 8~10mps | 160± 10 ㎛ |
DWF8 | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | 10.0 mg 5.0 g 10.0 g 1.0 g 0.1 g 10.0 g 적량 | 12~15mps | 160± 10 ㎛ |
DWF9 | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | 10.0 mg 5.0 g 10.0 g 0.5 g 0.05 g 10.0 g 적량 | 7~9mps | 155± 10 ㎛ |
DWF10 | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | 10.0 mg 5.0 g 10.0 g 2.0 g 0.05 g 10.0 g 적량 | 17~20mps | 165± 10 ㎛ |
DWF11 | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | 5.0 mg 5.0 g 10.0 g 1.0 g 0.05 g 10.0 g 적량 | 8~10mps | 160± 10 ㎛ |
처방 | 조성 | 함량(100g 중) | 점도 | 두께 |
DWF12 | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | 1.0 mg 5.0 g 10.0 g 1.0 g 0.05 g 10.0 g 적량 | 8~10mps | 160± 10 ㎛ |
DWF13 (2.0mm 캐스팅) | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | (전체:125g중) 10.0 mg 6.25. g 12.5 g 1.25 g 0.125 g 12.5 g 적량 | 12~15mps | 300± 10 ㎛ |
DWF14 (3.0mm 캐스팅) | 상피세포성장인자 키토산 하이드록시프로필메틸셀룰로오즈50cps 하이드록시프로필메틸셀룰로오즈4000cps 풀루란 글리세린 정제수 | (전체:150g중) 10.0 mg 7.5 g 15.0 g 1.5 g 0.15 g 15.0 g 적량 | 12~15mps | 455± 10 ㎛ |
시간 (hr) | 상피세포성장인자 방출량 % (평균 ± 표준편차) | |||||
DWF7 | DWF8 | DWF9 | DWF10 | DWF11 | DWF12 | |
1 | 3.5 ± 1.25 | 2.3 ± 1.23 | 5.4 ± 2.35 | 0.9 ± 0.20 | 2.1 ± 0.91 | 1.2 ± 0.09 |
3 | 5.7 ± 2.34 | 3.4 ± 1.10 | 11.3 ± 2.43 | 2.1 ± 1.12 | 4.3 ± 1.25 | 3.2 ± 1.20 |
6 | 23.0 ± 2.24 | 15.2 ± 3.2 | 30.2 ± 3.50 | 9.2 ± 1.26 | 19.2 ± 2.30 | 14.1 ± 2.34 |
9 | 47.0 ± 2.53 | 36.2 ± 2.35 | 56.3 ± 2.26 | 15.2 ± 2.35 | 38.2 ± 2.5 | 29.3 ± 3.23 |
15 | 69.2 ± 1.92 | 54.3 ± 3.26 | 78.2 ± 4.30 | 45.3 ± 3.24 | 62.1 ± 3.63 | 53.2 ± 2.12 |
18 | 79.3 ± 1.20 | 68.2 ± 4.24 | 83.2 ± 3.64 | 60.2 ± 3.24 | 70.21 ± 4.24 | 65.3 ± 2.51 |
24 | 97.5 ± 2.10 | 89.3 ± 3.24 | 98.1 ± 2.12 | 78.2 ± 4.53 | 91.2 ± 3.40 | 81.3 ± 1.92 |
시간 (hr) | 상피세포성장인자 방출량 % (평균 ± 표준편차) | ||
DWF8 (160± 10 ㎛) | DWF13 (300± 10 ㎛) | DWF14 (455± 10 ㎛) | |
1 | 2.3 ± 1.23 | 0.3 ± 0.23 | 0.4 ± 0.35 |
3 | 3.4 ± 1.10 | 2.4 ± 1.10 | 1.3 ± 1.43 |
6 | 15.2 ± 3.2 | 8.2 ± 3.8 | 8.2 ± 2.50 |
9 | 36.2 ± 2.35 | 21.2 ± 3.35 | 12.3 ± 2.26 |
15 | 54.3 ± 3.26 | 40.3 ± 4.26 | 26.2 ± 4.30 |
18 | 68.2 ± 4.24 | 58.2 ± 2.24 | 41.2 ± 3.64 |
24 | 89.3 ± 3.24 | 79.3 ± 4.24 | 68.1 ± 2.12 |
처방 | 조성 (100g 중) | 필름 두께 |
DWF15 (-) | 상피세포성장인자 1.0 mg 키토산 5.0 g 하이드록시프로필메틸셀룰로오즈50cps 10.0 g 하이드록시프로필메틸셀룰로오즈4000cps 1.0 g 풀루란 0.05 g 글리세린 10.0 g 정제수 적량 | 160±10 ㎛ |
DWF16 (L-히스티딘) | 상피세포성장인자 1.0 mg 키토산 5.0 g 하이드록시프로필메틸셀룰로오즈50cps 10.0 g 하이드록시프로필메틸셀룰로오즈4000cps 1.0 g 풀루란 0.05 g 글리세린 10.0 g L-히스티딘 0.1 g 정제수 적량 | 160±10 ㎛ |
DWF17 (EDTA) | 상피세포성장인자 1.0 mg 키토산 5.0 g 하이드록시프로필메틸셀룰로오즈50cps 10.0 g 하이드록시프로필메틸셀룰로오즈4000cps 1.0 g 풀루란 0.05 g 글리세린 10.0 g EDTA Disodium 0.05 g 정제수 적량 | 160±10 ㎛ |
처방 | 조성 (100g 중) | 필름 두께 |
DWF18 (아스코르빈산) | 상피세포성장인자 1.0 mg 키토산 5.0 g 하이드록시프로필메틸셀룰로오즈50cps 10.0 g 하이드록시프로필메틸셀룰로오즈4000cps 1.0 g 풀루란 0.05 g 글리세린 10.0 g 아스코르빈산 0.05 g 정제수 적량 | 160±10 ㎛ |
DWF19 (EDTA+L-히스티딘) | 상피세포성장인자 1.0 mg 키토산 5.0 g 하이드록시프로필메틸셀룰로오즈50cps 10.0 g 하이드록시프로필메틸셀룰로오즈4000cps 1.0 g 풀루란 0.05 g 글리세린 10.0 g EDTA Disodium 0.05 g L-히스티딘 0.1 g 정제수 적량 | 160±10 ㎛ |
DWF20 (EDTA+포스페이트버퍼) | 상피세포성장인자 1.0 mg 키토산 5.0 g 하이드록시프로필메틸셀룰로오즈50cps 10.0 g 하이드록시프로필메틸셀룰로오즈4000cps 1.0 g 풀루란 0.05 g 글리세린 10.0 g EDTA Disodium 0.05 g 인산일수소나트륨 0.142g 정제수 적량 | 160±10 ㎛ |
구 분 | 25℃(3개월) | 2 ~ 8℃(1년) | ||
함량(%) | 활성(%) | 함량(%) | 활성(%) | |
DWF15 | 77.0 | 68.0 | 87.3 | 87.1 |
DWF16 | 90.9 | 89.1 | 94.4 | 93.3 |
DWF17 | 93.7 | 91.2 | 98.1 | 97.2 |
DWF18 | 92.8 | 91.5 | 96.9 | 97.1 |
DWF19 | 95.0 | 94.5 | 99.9 | 98.9 |
DWF20 | 94.5 | 93.9 | 98.2 | 99.1 |
대조군 | 비교군 | |
일반 필름 [25ug/1매(20cm2)] | 본원발명의 서방성 필름 제형(DWF20) [50ug/1매(20cm2)] | |
용법 및 용량 | 하루 2회 1장씩 상처부위에 붙인다. (12시간 간격) | 하루 1장 상처부위에 붙인다. |
평가기간 | 4일 | |
상처부위면적 | 약 20cm2 |
Claims (15)
- 상피세포성장인자; 키토산; 하이드록시프로필메틸셀룰로오즈, 젤란검 및 풀루란 중에서 선택된 하나 이상인 점도 조절제; 글리세린, 프로필렌글리콜, 폴리에틸렌글리콜, 폴리비닐알콜 및 폴리비닐피롤리돈 중에서 선택된 하나 이상인 가소제; 및 EDTA 및 비타민 C 중에서 선택된 하나 이상인 항산화제를 포함하는 상처치료용 서방성 필름 제형.
- 제1항에 있어서, 인산일수소나트륨, 탄산수소나트륨 및 구연산 나트륨 중에서 선택된 하나 이상인 완충제를 추가로 포함하는 필름 제형.
- 제1항에 있어서, L-히스티딘, L-라이신 및 L-아르기닌 중에서 선택된 하나 이상인 아미노산을 추가로 포함하는 필름 제형.
- 제1항에 있어서, 키토산은 분자량이 10 kDa 내지 150 kDa인 필름 제형.
- 제1항 또는 제4항에 있어서, 키토산의 함량이 전체 중량 대비 1 내지 10 w/w%인 필름 제형.
- 제1항에 있어서, 상피세포성장인자의 함량이 전체 중량 대비 0.1 내지 10,000μg/g인 필름 제형.
- 제1항에 있어서, 하이드록시프로필메틸셀룰로오즈는 점도가 5 내지 100,000 cps인 것 중에서 선택된 하나 이상인 필름 제형.
- 제1항 또는 제7항에 있어서, 하이드록시프로필메틸셀룰로오즈는 10 내지 100cps의 저점도 하이드록시프로필메틸셀룰로오즈 및 1,000 내지 100,000 cps의 고점도 하이드록시프로필메틸셀룰로오즈를 포함하는 필름 제형.
- 제1항 또는 제7항에 있어서, 점도 조절제의 함량이 전체 중량 대비 0.01 내지 20 w/w %인 필름 제형.
- 제1항에 있어서, 가소제의 함량이 전체 중량 대비 1 내지 40 w/w%인 필름 제형.
- 제1항에 있어서, 항산화제의 함량이 전체 중량 대비 0.01 내지 10 w/w%인 필름 제형.
- 제1항에 있어서, 필름 제형의 점도가 1,000 내지 150,000 cps인 필름 제형.
- 제1항에 있어서, 필름의 두께가 0.001 내지 1 mm인 필름 제형.
- 삭제
- 삭제
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050108344A KR100748390B1 (ko) | 2005-11-14 | 2005-11-14 | 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 |
PCT/KR2006/004401 WO2007055481A1 (en) | 2005-11-14 | 2006-10-27 | Sustained release film formulation for healing wound comprising epidermal growth factor |
JP2008539915A JP4937269B2 (ja) | 2005-11-14 | 2006-10-27 | 上皮細胞成長因子を含む創傷治療用の徐放性フィルム製剤 |
EP06812242.3A EP1951328B1 (en) | 2005-11-14 | 2006-10-27 | Sustained release film formulation for healing wound comprising epidermal growth factor |
CN2006800447466A CN101316618B (zh) | 2005-11-14 | 2006-10-27 | 包含表皮生长因子的用于愈合伤口的缓释膜剂 |
US12/093,551 US20090047331A1 (en) | 2005-11-14 | 2006-10-27 | Sustained release film formulation for healing wound comprising epidermal growth factor |
ES06812242.3T ES2453567T3 (es) | 2005-11-14 | 2006-10-27 | Formulación pelicular de liberación sostenida para la curación de heridas que comprende factor de crecimiento epidérmico |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050108344A KR100748390B1 (ko) | 2005-11-14 | 2005-11-14 | 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20070051009A KR20070051009A (ko) | 2007-05-17 |
KR100748390B1 true KR100748390B1 (ko) | 2007-08-10 |
Family
ID=38023438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050108344A KR100748390B1 (ko) | 2005-11-14 | 2005-11-14 | 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20090047331A1 (ko) |
EP (1) | EP1951328B1 (ko) |
JP (1) | JP4937269B2 (ko) |
KR (1) | KR100748390B1 (ko) |
CN (1) | CN101316618B (ko) |
ES (1) | ES2453567T3 (ko) |
WO (1) | WO2007055481A1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014126370A1 (en) | 2013-02-13 | 2014-08-21 | Dong-A Pharmaceutical Co.,Ltd | Film-forming pharmaceutical composition for wound healing and method for preparing the same |
KR20190116693A (ko) | 2018-04-05 | 2019-10-15 | 주식회사 엔씨엘바이오 | 사람 상피세포 성장인자, 펩타이드 및 기능성 소재를 함유하는 피부 상태 개선용 화장료 조성물 |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY185299A (en) * | 2007-10-11 | 2021-04-30 | Philip Morris Products Sa | Smokeless tobacco product |
JP5618602B2 (ja) * | 2010-04-16 | 2014-11-05 | ツキオカフィルム製薬株式会社 | フィルム製剤 |
US20140249102A1 (en) * | 2010-09-01 | 2014-09-04 | Battelle Memorial Institute | Topical Applicator Composition and Process for Treatment of Radiologically Contaminated Dermal Injuries |
CN102020710B (zh) * | 2010-09-03 | 2012-09-05 | 深圳市华生元基因工程发展有限公司 | 人表皮生长因子一个新的突变体en-46 |
US9433682B2 (en) * | 2012-02-23 | 2016-09-06 | University South Florida | Graphene hydrogel and method for using the same |
CN102634042A (zh) * | 2012-04-20 | 2012-08-15 | 浙江大学 | 一种具有生物活性的聚乙烯醇复合水凝胶及其制备方法 |
CN102764447B (zh) * | 2012-07-27 | 2014-02-05 | 武汉人福医疗用品有限公司 | 水凝胶敷料及其制备工艺 |
CN102784416B (zh) * | 2012-08-28 | 2014-04-02 | 福州乾正药业有限公司 | 一种助分娩凝胶 |
US9579388B2 (en) | 2012-11-29 | 2017-02-28 | Rene Gauthier | System and method for alleviating the appearance of scars and/or scar tissue |
CN103356692B (zh) * | 2013-07-24 | 2015-09-30 | 广东泰宝医疗科技股份有限公司 | 一种复合抗菌凝胶剂及其制备方法 |
CN103933603B (zh) * | 2014-04-16 | 2015-12-02 | 广西信业生物技术有限公司 | 一种壳聚糖促人表皮生长生物医用胶及其制备方法 |
CN104436288B (zh) * | 2014-11-10 | 2017-02-08 | 南安市永腾技术咨询有限公司 | 一种复合医用水凝胶敷料材料及其制备方法 |
CN104740677B (zh) * | 2015-04-23 | 2017-06-06 | 广西达庆生物科技股份有限公司 | 一种皮肤医用修复敷料及其制备方法 |
US11998644B2 (en) | 2015-10-16 | 2024-06-04 | Amolifescience Co., Ltd. | Dry pad |
CN105999368A (zh) * | 2016-07-28 | 2016-10-12 | 上海建华精细生物制品有限公司 | 表皮生长因子复合湿性创伤敷料及其制备方法 |
CN106110389A (zh) * | 2016-08-30 | 2016-11-16 | 上海建华精细生物制品有限公司 | 一种皮肤创面用的湿性敷料及其制备方法和应用 |
KR102340750B1 (ko) | 2017-03-03 | 2021-12-21 | 에이치엘비테라퓨틱스 주식회사 | 티모신 베타 4를 유효성분으로 포함하는 안정화된 외용 제제 |
CN109568644A (zh) * | 2017-09-29 | 2019-04-05 | 温州医科大学 | 一种复合生长因子抗菌促修复凝胶及其制备方法与应用 |
CN108653718B (zh) * | 2018-05-31 | 2022-03-11 | 广州润虹医药科技股份有限公司 | 一种可吸收促愈合止血组合物及敷料 |
CN108653800A (zh) * | 2018-06-06 | 2018-10-16 | 中国医学科学院生物医学工程研究所 | 含生物活性玻璃和/或精氨酸的创面修复敷料及其制备方法与应用 |
KR102028131B1 (ko) * | 2018-07-13 | 2019-10-02 | 이민우 | 드레싱제 |
CN108969795B (zh) * | 2018-08-29 | 2019-09-10 | 海南一鸿实业发展有限公司 | 一种用于难愈合性创面功能性液体敷料及其制备方法 |
CN109528692B (zh) * | 2018-12-03 | 2020-11-10 | 王丽萍 | 浓缩生长因子缓释冻干膜及其制备方法 |
CN109846859A (zh) * | 2018-12-29 | 2019-06-07 | 广州艾蓓生物科技有限公司 | 一种修复型医用冷敷贴及其制备方法 |
CN109793913A (zh) * | 2019-01-18 | 2019-05-24 | 杭州美迪生物医药技术开发有限公司 | 包含表皮生长因子的缓释膜敷料 |
CN110314224A (zh) * | 2019-07-19 | 2019-10-11 | 西北大学 | 一种促进皮肤损伤愈合的贴膜及其制备方法和应用 |
CN113861472B (zh) * | 2021-11-08 | 2023-06-06 | 中国热带农业科学院南亚热带作物研究所 | 两亲性壳聚糖/改性结冷胶复合膜的制备方法 |
CN114316306A (zh) * | 2021-12-30 | 2022-04-12 | 普丽妍(南京)医疗科技有限公司 | 一种可注射温敏水凝胶的制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890004720A (ko) * | 1987-09-18 | 1989-05-09 | 원본미기재 | 성장 인자를 함유하는 겔 제형 |
US5840338A (en) * | 1994-07-18 | 1998-11-24 | Roos; Eric J. | Loading of biologically active solutes into polymer gels |
KR20000038061A (ko) * | 1998-12-03 | 2000-07-05 | 김효근 | 상처치료용 드레싱제의 제조방법 |
KR20020057210A (ko) * | 2000-12-30 | 2002-07-11 | 강은숙 | 인터넷을 이용한 가구 인테리어 서비스방법 |
US20020111576A1 (en) * | 2000-12-29 | 2002-08-15 | Kimberly-Clark Worldwide, Inc. | Bioabsorbable wound dressing |
US20030203011A1 (en) * | 2002-04-12 | 2003-10-30 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
KR20050086040A (ko) * | 2004-02-24 | 2005-08-30 | 한국원자력연구소 | 상피세포성장인자-키토산 복합체 및 그의 제조방법 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ235556A (en) * | 1986-11-05 | 1991-06-25 | Ethicon Inc | Breast milk substitute containing recombinant human egf |
US5457093A (en) * | 1987-09-18 | 1995-10-10 | Ethicon, Inc. | Gel formulations containing growth factors |
US4944948A (en) * | 1989-02-24 | 1990-07-31 | Liposome Technology, Inc. | EGF/Liposome gel composition and method |
JPH0543453A (ja) * | 1991-08-20 | 1993-02-23 | Sumitomo Pharmaceut Co Ltd | 創傷治癒促進用局所用徐放性製剤 |
JP3572092B2 (ja) * | 1993-09-17 | 2004-09-29 | 帝國製薬株式会社 | 線維芽細胞成長因子含有フィルム製剤 |
DE19503336C2 (de) * | 1995-02-02 | 1998-07-30 | Lohmann Therapie Syst Lts | Arzneiform zur Abgabe von Wirkstoffen an Wunden, Verfahren zu ihrer Herstellung und ihre Verwendung |
JPH11507697A (ja) * | 1995-06-09 | 1999-07-06 | エヌ. ドロハン,ウィリアム | キチンヒドロゲル、それらの製造方法及び利用 |
CN1056086C (zh) * | 1996-07-08 | 2000-09-06 | 韩建礼 | 生物敷料制品及其制法 |
US5836970A (en) * | 1996-08-02 | 1998-11-17 | The Kendall Company | Hemostatic wound dressing |
US6395029B1 (en) * | 1999-01-19 | 2002-05-28 | The Children's Hospital Of Philadelphia | Sustained delivery of polyionic bioactive agents |
US7033603B2 (en) * | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
KR100366439B1 (ko) * | 2000-02-21 | 2003-01-09 | 주식회사 대웅 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
JP2003012702A (ja) * | 2001-04-24 | 2003-01-15 | Sankyo Co Ltd | 低分子キトサンの製造方法 |
CN1363398A (zh) * | 2002-01-16 | 2002-08-14 | 吉林大学 | 以壳多糖或其衍生物为基质网架的复层人工皮肤 |
WO2004028557A1 (ja) * | 2002-09-26 | 2004-04-08 | Shionogi & Co., Ltd. | 安定化されたタンパク組成物 |
JP2004161684A (ja) * | 2002-11-13 | 2004-06-10 | Nitto Denko Corp | 生理活性物質含有創傷治癒用フィルム製剤 |
-
2005
- 2005-11-14 KR KR1020050108344A patent/KR100748390B1/ko active IP Right Grant
-
2006
- 2006-10-27 ES ES06812242.3T patent/ES2453567T3/es active Active
- 2006-10-27 US US12/093,551 patent/US20090047331A1/en not_active Abandoned
- 2006-10-27 WO PCT/KR2006/004401 patent/WO2007055481A1/en active Application Filing
- 2006-10-27 CN CN2006800447466A patent/CN101316618B/zh active Active
- 2006-10-27 EP EP06812242.3A patent/EP1951328B1/en active Active
- 2006-10-27 JP JP2008539915A patent/JP4937269B2/ja active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR890004720A (ko) * | 1987-09-18 | 1989-05-09 | 원본미기재 | 성장 인자를 함유하는 겔 제형 |
US5840338A (en) * | 1994-07-18 | 1998-11-24 | Roos; Eric J. | Loading of biologically active solutes into polymer gels |
KR20000038061A (ko) * | 1998-12-03 | 2000-07-05 | 김효근 | 상처치료용 드레싱제의 제조방법 |
US20020111576A1 (en) * | 2000-12-29 | 2002-08-15 | Kimberly-Clark Worldwide, Inc. | Bioabsorbable wound dressing |
KR20020057210A (ko) * | 2000-12-30 | 2002-07-11 | 강은숙 | 인터넷을 이용한 가구 인테리어 서비스방법 |
US20030203011A1 (en) * | 2002-04-12 | 2003-10-30 | 3M Innovative Properties Company | Gel materials, medical articles, and methods |
KR20050086040A (ko) * | 2004-02-24 | 2005-08-30 | 한국원자력연구소 | 상피세포성장인자-키토산 복합체 및 그의 제조방법 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014126370A1 (en) | 2013-02-13 | 2014-08-21 | Dong-A Pharmaceutical Co.,Ltd | Film-forming pharmaceutical composition for wound healing and method for preparing the same |
US10278928B2 (en) | 2013-02-13 | 2019-05-07 | Dong-A Pharmaceutical Co., Ltd | Film-forming pharmaceutical composition for wound healing and method for preparing the same |
KR20190116693A (ko) | 2018-04-05 | 2019-10-15 | 주식회사 엔씨엘바이오 | 사람 상피세포 성장인자, 펩타이드 및 기능성 소재를 함유하는 피부 상태 개선용 화장료 조성물 |
KR102101920B1 (ko) | 2018-04-05 | 2020-05-18 | 주식회사 메타랩스 | 사람 상피세포 성장인자, 펩타이드 및 기능성 소재를 함유하는 피부 상태 개선용 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
EP1951328A1 (en) | 2008-08-06 |
CN101316618B (zh) | 2011-12-14 |
KR20070051009A (ko) | 2007-05-17 |
US20090047331A1 (en) | 2009-02-19 |
WO2007055481A1 (en) | 2007-05-18 |
JP4937269B2 (ja) | 2012-05-23 |
CN101316618A (zh) | 2008-12-03 |
JP2009515873A (ja) | 2009-04-16 |
ES2453567T3 (es) | 2014-04-08 |
EP1951328B1 (en) | 2014-03-05 |
EP1951328A4 (en) | 2012-05-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100748390B1 (ko) | 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 | |
Draye et al. | In vitro and in vivo biocompatibility of dextran dialdehyde cross-linked gelatin hydrogel films | |
US20210213039A1 (en) | Composition containing ectoine or hydroxyectoine as an active substance for promoting the regeneration of injured body tissue | |
RU2424824C2 (ru) | Комплекс амфифильный полимер-pdgf | |
AU2005218925B2 (en) | Pharmaceutical composition for topical use in form of xerogels or films and methods for production | |
EP3017808B1 (en) | Water-soluble hyaluronic acid gel and method for producing same | |
EP2059206B1 (en) | Dry wound dressing and drug delivery system | |
JP3761816B2 (ja) | 上皮細胞成長因子を有効成分とする安定した組成物 | |
KR100784134B1 (ko) | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 | |
CN110859989B (zh) | 一种液体创可贴及其制备方法 | |
US20110104279A1 (en) | Healing powder and method of use thereof | |
EP1666075A1 (en) | Wound dressing compositions, especially for delivery of protease inhibitors | |
JP2002505299A (ja) | ヒト上皮成長因子を含有する皮膚外用剤組成物 | |
CN113616849B (zh) | 一种用于外部伤口护理的液体敷料及其制备方法 | |
WO2005077402A1 (en) | Honey based gel formulations | |
JPH0782171A (ja) | 線維芽細胞成長因子含有フィルム製剤 | |
CN111588837B (zh) | 一种蛋白-纳米银复合物的制备方法及制备的复合物和用途 | |
JP2013155120A (ja) | 皮膚潰瘍治癒促進外用剤 | |
CN116832143A (zh) | 一种用于全层皮肤损伤创面愈合的pdgf制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Re-publication after modification of scope of protection [patent] | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140306 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150306 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170410 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180404 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 13 |